Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-13

Clinical Trial Update: Flortaucipir 18F PET Imaging in BIOCARD Study [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for Flortaucipir 18F PET imaging in the BIOCARD study; terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Flortaucipir 18F (flortaucipir)

Snippet

Sponsor: Avid Radiopharmaceuticals | Conditions: Cognitive Decline | Phase 1 | Status: TERMINATED | Results posted: 2020-08-13